🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 5 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/02/2020 43,25 45,00 40,00 43,98 -28,45% 11,56% 5.813.800
27/02/2020 59,86 63,59 56,89 61,47 +0,36% 11,19% 948.700
26/02/2020 60,88 61,90 59,70 61,25 +1,34% 3,61% 321.700
25/02/2020 62,88 63,51 60,04 60,44 -3,77% 5,53% 426.100
24/02/2020 61,30 62,91 61,05 62,81 -1,81% 3,03% 521.700
21/02/2020 65,32 65,32 61,81 63,97 -2,34% 5,37% 657.200
20/02/2020 66,98 67,21 65,18 65,50 -2,75% 3,03% 699.700
19/02/2020 67,91 68,82 67,21 67,35 -0,80% 2,38% 342.600
18/02/2020 67,11 68,07 65,84 67,89 +0,83% 3,32% 484.700
14/02/2020 70,32 70,57 66,90 67,33 -4,01% 5,22% 482.500
13/02/2020 69,58 70,96 68,08 70,14 +0,47% 4,14% 530.300
12/02/2020 67,09 70,25 66,26 69,81 +4,62% 5,95% 527.700
11/02/2020 65,85 67,80 65,37 66,73 +2,33% 3,69% 505.100
10/02/2020 63,69 65,26 62,37 65,21 +2,61% 4,54% 534.800
07/02/2020 62,03 63,58 61,45 63,55 +2,15% 3,43% 566.800
06/02/2020 60,92 62,21 59,68 62,21 +2,61% 4,15% 515.100
05/02/2020 60,44 61,13 59,22 60,63 +1,73% 3,16% 536.400
04/02/2020 58,58 59,93 57,27 59,60 +3,74% 4,54% 486.300
03/02/2020 56,69 57,49 56,49 57,45 +2,13% 1,76% 207.100
31/01/2020 57,22 57,22 54,94 56,25 -2,09% 3,98% 277.700
30/01/2020 56,86 57,57 55,71 57,45 -0,10% 3,28% 279.400
29/01/2020 58,20 58,49 57,38 57,51 -0,78% 1,91% 186.100
28/01/2020 56,77 58,07 55,85 57,96 +2,53% 3,91% 238.200
27/01/2020 56,56 57,62 56,09 56,53 -1,94% 2,71% 283.700
24/01/2020 57,71 58,05 57,02 57,65 +0,07% 1,78% 531.900
23/01/2020 58,00 58,28 56,72 57,61 -0,60% 2,69% 532.300
22/01/2020 58,45 58,69 57,69 57,96 +0,07% 1,71% 210.300
21/01/2020 57,20 58,16 56,20 57,92 +0,99% 3,43% 339.600
17/01/2020 59,15 59,50 57,26 57,35 -2,43% 3,79% 258.600
16/01/2020 58,44 59,68 57,86 58,78 +1,36% 3,11% 276.400